Eli Lilly and Co News

Morgan Stanley Raises Price Target on Eli Lilly to $1,023 From $950 Amid 2024 Guidance Boost, Keeps Overweight Rating

MT Newswires22minutes ago

Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Raises Price Target to $885

Benzinga13:46 ET

Eli Lilly and Co Analyst Ratings

Benzinga13:45 ET

Jefferies Adjusts Eli Lilly and Co.'s Price Target to $915 From $895, Keeps Buy Rating

MT NewswiresApr 30 11:54 ET

Eli Lilly and Co Analyst Ratings

BenzingaApr 18 09:53 ET

Eli Lilly Stock (NYSE:LLY): Hold Off Until the End of the Month

TipRanksApr 17 14:25 ET

Eli Lilly and Co Analyst Ratings

BenzingaApr 15 14:29 ET

Eli Lilly and Co Analyst Ratings

BenzingaApr 11 09:04 ET

Goldman Sachs Maintains Neutral on Eli Lilly and Co, Raises Price Target to $723

BenzingaApr 11 09:05 ET

Eli Lilly and Co Analyst Ratings

BenzingaApr 5 09:23 ET

Eli Lilly and Co Analyst Ratings

BenzingaApr 3 13:29 ET

Eli Lilly and Co Analyst Ratings

BenzingaApr 2 15:50 ET

Eli Lilly and Co Analyst Ratings

BenzingaApr 1 08:35 ET

Eli Lilly and Co Analyst Ratings

BenzingaMar 22 14:44 ET

Eli Lilly and Co Analyst Ratings

BenzingaMar 15 10:04 ET

Wells Fargo Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

TipRanksMar 15 05:17 ET

Research Alert: CFRA Adds Eli Lilly To The High-quality Capital Appreciation Portfolio

MT NewswiresMar 13 12:20 ET

Research Alert: CFRA Adds Eli Lilly To The High-quality Capital Appreciation Portfolio

MT NewswiresMar 5 23:45 ET

Eli Lilly and Co Analyst Ratings

BenzingaMar 1 12:41 ET

Jim Cramer Weighs In On Palo Alto, Eli Lilly And Salesforce, Says Price Target Bump For This Stock A 'Red Flag'

BenzingaFeb 28 03:59 ET